rss
Br J Ophthalmol 1998;82:758-762 doi:10.1136/bjo.82.7.758
  • Original Article
    • Clinical science

Topical carbonic anhydrase inhibition increases ocular pulse amplitude in high tension primary open angle glaucoma

  1. Karl-Georg Schmidta,
  2. Andrea von Rückmanna,
  3. Lutz E Pillunatb
  1. aDepartment of Ophthalmology, Justus Liebig University, Giessen, Germany, bDepartment of Ophthalmology, University of Hamburg, Hamburg, Germany
  1. Dr med K-G Schmidt, Universitäts-Augenklinik, Friedrichstrasse 18, D-35385 Giessen, Germany.
  • Accepted 29 January 1998

Abstract

BACKGROUND Ocular pulse amplitude (OPA) is reduced in normal tension primary open angle glaucoma (NTP) patients when compared with healthy age matched controls (CTL) while increased OPA appears to protect ocular hypertensive patients from visual field loss. If NTP is accompanied by vasospasm, as in roughly half of the primary open angle glaucoma (POAG) population (independent of intraocular pressure, IOP), calcium channel blockers increase OPA and thus stabilise visual fields in these patients. Current glaucoma drugs reduce IOP but do not activate (compromised) ocular perfusion.

METHODS The influence of dorzolamide, a topical carbonic anhydrase inhibitor in standard dosage (three times daily, one eye) on OPA, IOP, blood pressure, and heart rate was investigated in a randomised, prospective, masked clinical trial assessing the acute effects of dorzolamidev placebo before and 2 days after application in 33 cataract patients with (n = 14) and without (n = 19) high tension POAG (HTP) who provided informed consent.

RESULTS Following application of dorzolamide (D) IOP (mm Hg, mean (SEM)) in HTPD (20.2 (0.5)/16.3 (0.5)) and in CTLD (16.0 (0.5)/12.3 (0.5)) was highly significantly (p <0.001) reduced and was significantly (p<0.03) reduced in vehicle (V) treated eyes (HTPV: 20.3 (0.4)/19.0 (0.4)) and CTLV: 15.8 (0.4)/14.9 (0.3)) when compared with respective baseline measurements. OPA (mm Hg) in HTPD (2.1 (0.1)/2.5 (0.1)) and CTLD (2.2 (0.1)/2.6 (0.2)) eyes was significantly (p<0.05) increased and unaffected in vehicle treated eyes when compared with respective baseline measurements. Systemic perfusion variables were also unchanged.

CONCLUSION Dorzolamide increased OPA in HTP and CTL. Drugs stimulating OPA may improve prognosis of POAGs.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Services

    1. Email this link to a friend
    2. Alert me when this article is cited
    3. Alert me if a correction is posted
    4. Alert me when eletters are published
    5. Article Usage Statistics
    6. Similar articles in this journal
    7. Similar articles in Web of Science
    8. Similar articles in PubMed
    9. Add article to my folders
    10. Download to citation manager
    11. Request permissions

    Responses

    1. Submit a response
    2. No responses published

    Social bookmarking

    Register for free content


    Free sample
     This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
    View free sample issue >>

    Free archive
    The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
    Register to access the free archive >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.